HK1044707B - 糖肽抗體用於長期預防肺炎鏈球菌感染的每月劑量 - Google Patents

糖肽抗體用於長期預防肺炎鏈球菌感染的每月劑量

Info

Publication number
HK1044707B
HK1044707B HK02104765.3A HK02104765A HK1044707B HK 1044707 B HK1044707 B HK 1044707B HK 02104765 A HK02104765 A HK 02104765A HK 1044707 B HK1044707 B HK 1044707B
Authority
HK
Hong Kong
Prior art keywords
long
streptococcus pneumoniae
glycopeptide antibiotics
term prevention
pneumoniae infections
Prior art date
Application number
HK02104765.3A
Other languages
English (en)
Chinese (zh)
Other versions
HK1044707A1 (en
Inventor
Reeves Parr Thomas
Mary Wasilewski Margaret
Lee Zeckel Michel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1044707A1 publication Critical patent/HK1044707A1/xx
Publication of HK1044707B publication Critical patent/HK1044707B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02104765.3A 1999-05-03 2002-06-26 糖肽抗體用於長期預防肺炎鏈球菌感染的每月劑量 HK1044707B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (en) 1999-05-03 2000-04-19 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections

Publications (2)

Publication Number Publication Date
HK1044707A1 HK1044707A1 (en) 2002-11-01
HK1044707B true HK1044707B (zh) 2005-09-30

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104765.3A HK1044707B (zh) 1999-05-03 2002-06-26 糖肽抗體用於長期預防肺炎鏈球菌感染的每月劑量

Country Status (29)

Country Link
EP (1) EP1175222B1 (xx)
JP (1) JP2002543146A (xx)
KR (1) KR100757165B1 (xx)
CN (1) CN1349407A (xx)
AR (1) AR023827A1 (xx)
AT (1) ATE284702T1 (xx)
AU (1) AU774647B2 (xx)
BR (1) BR0010244A (xx)
CA (1) CA2372790A1 (xx)
CZ (1) CZ296127B6 (xx)
DE (1) DE60016734T2 (xx)
DZ (1) DZ3039A1 (xx)
EA (1) EA004295B1 (xx)
HK (1) HK1044707B (xx)
HR (1) HRP20010808A2 (xx)
HU (1) HUP0200940A3 (xx)
IL (2) IL145582A0 (xx)
MY (1) MY123542A (xx)
NO (1) NO20015291L (xx)
NZ (1) NZ514467A (xx)
PE (1) PE20010292A1 (xx)
PL (1) PL353444A1 (xx)
SK (1) SK285970B6 (xx)
SV (1) SV2002000065A (xx)
TR (1) TR200103211T2 (xx)
TW (1) TWI255716B (xx)
UA (1) UA73937C2 (xx)
WO (1) WO2000066144A2 (xx)
ZA (1) ZA200108013B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102215858A (zh) * 2008-08-30 2011-10-12 塔尔甘塔治疗公司 使用单剂量奥利万星的治疗方法
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
TWI255716B (en) 2006-06-01
MY123542A (en) 2006-05-31
NO20015291L (no) 2001-12-17
TR200103211T2 (tr) 2002-02-21
CN1349407A (zh) 2002-05-15
KR20020008173A (ko) 2002-01-29
WO2000066144A2 (en) 2000-11-09
NO20015291D0 (no) 2001-10-29
DZ3039A1 (fr) 2004-03-27
HRP20010808A2 (en) 2002-12-31
SK15572001A3 (sk) 2003-05-02
DE60016734D1 (de) 2005-01-20
UA73937C2 (en) 2005-10-17
PL353444A1 (en) 2003-11-17
AR023827A1 (es) 2002-09-04
ATE284702T1 (de) 2005-01-15
EP1175222B1 (en) 2004-12-15
EA004295B1 (ru) 2004-02-26
SK285970B6 (sk) 2007-12-06
HUP0200940A3 (en) 2002-10-28
NZ514467A (en) 2005-01-28
IL145582A (en) 2008-12-29
WO2000066144A3 (en) 2001-04-12
IL145582A0 (en) 2002-06-30
HUP0200940A2 (en) 2002-08-28
ZA200108013B (en) 2003-03-26
HK1044707A1 (en) 2002-11-01
BR0010244A (pt) 2002-01-08
CZ20013949A3 (cs) 2002-07-17
SV2002000065A (es) 2002-12-02
KR100757165B1 (ko) 2007-09-07
PE20010292A1 (es) 2001-03-07
DE60016734T2 (de) 2005-12-08
JP2002543146A (ja) 2002-12-17
EA200101171A1 (ru) 2002-04-25
CZ296127B6 (cs) 2006-01-11
EP1175222A2 (en) 2002-01-30
CA2372790A1 (en) 2000-11-09
AU774647B2 (en) 2004-07-01
AU4329200A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
HK1043728A1 (en) Vaccine against streptococcus pneumoniae
EP1363925B8 (en) Macrolide antibiotics
AU2002217277A1 (en) Macrolide antibiotics
EP1144432A4 (en) STEROID-BASED ANTIBIOTICS
IL148641A0 (en) Topical treatment of streptococcal infections
IL144178A0 (en) Ketolide antibiotics
AU2001272719A1 (en) Macrolide antibiotics
PL348114A1 (en) Novel macrolide antibiotics
HK1016477A1 (en) Antibacterial composition for oral administration
AU5029700A (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
HK1044707B (zh) 糖肽抗體用於長期預防肺炎鏈球菌感染的每月劑量
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
HUP0003409A3 (en) Use of macrolide antibiotics for the prepartion of pharmaceutical compositions treating or preventing coccidiosis
GR20010300029T1 (en) Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions
AU2001238020A1 (en) Glycopeptide derivatives having antibiotic activity
AU1540501A (en) Streptococcus pneumoniae antigens
AU5493500A (en) Antibody-based treatment for streptococcus pneumoniae infection
HUP0101758A2 (hu) Penicillin és cefem antibiotikumot tartalmazó mikrobaellenes készítmény
AU4683299A (en) Detection of streptococcus pneumoniae and immunization against streptococcus pneumoniae infection
EP1200083A4 (en) ANTIBIOTIC COMPOUND
GB9912014D0 (en) Antibiotic antibody
AU2002307567A1 (en) Glycopeptide antibiotics
AU2002234868A1 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
ZA991412B (en) Derivatives of glycopeptide antibacterial agents.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090419